Cargando…

Regulators of complement activity mediate inhibitory mechanisms through a common C3b‐binding mode

Regulators of complement activation (RCA) inhibit complement‐induced immune responses on healthy host tissues. We present crystal structures of human RCA (MCP, DAF, and CR1) and a smallpox virus homolog (SPICE) bound to complement component C3b. Our structural data reveal that up to four consecutive...

Descripción completa

Detalles Bibliográficos
Autores principales: Forneris, Federico, Wu, Jin, Xue, Xiaoguang, Ricklin, Daniel, Lin, Zhuoer, Sfyroera, Georgia, Tzekou, Apostolia, Volokhina, Elena, Granneman, Joke CM, Hauhart, Richard, Bertram, Paula, Liszewski, M Kathryn, Atkinson, John P, Lambris, John D, Gros, Piet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868954/
https://www.ncbi.nlm.nih.gov/pubmed/27013439
http://dx.doi.org/10.15252/embj.201593673
_version_ 1782432235696160768
author Forneris, Federico
Wu, Jin
Xue, Xiaoguang
Ricklin, Daniel
Lin, Zhuoer
Sfyroera, Georgia
Tzekou, Apostolia
Volokhina, Elena
Granneman, Joke CM
Hauhart, Richard
Bertram, Paula
Liszewski, M Kathryn
Atkinson, John P
Lambris, John D
Gros, Piet
author_facet Forneris, Federico
Wu, Jin
Xue, Xiaoguang
Ricklin, Daniel
Lin, Zhuoer
Sfyroera, Georgia
Tzekou, Apostolia
Volokhina, Elena
Granneman, Joke CM
Hauhart, Richard
Bertram, Paula
Liszewski, M Kathryn
Atkinson, John P
Lambris, John D
Gros, Piet
author_sort Forneris, Federico
collection PubMed
description Regulators of complement activation (RCA) inhibit complement‐induced immune responses on healthy host tissues. We present crystal structures of human RCA (MCP, DAF, and CR1) and a smallpox virus homolog (SPICE) bound to complement component C3b. Our structural data reveal that up to four consecutive homologous CCP domains (i–iv), responsible for inhibition, bind in the same orientation and extended arrangement at a shared binding platform on C3b. Large sequence variations in CCP domains explain the diverse C3b‐binding patterns, with limited or no contribution of some individual domains, while all regulators show extensive contacts with C3b for the domains at the third site. A variation of ~100° rotation around the longitudinal axis is observed for domains binding at the fourth site on C3b, without affecting the overall binding mode. The data suggest a common evolutionary origin for both inhibitory mechanisms, called decay acceleration and cofactor activity, with variable C3b binding through domains at sites ii, iii, and iv, and provide a framework for understanding RCA disease‐related mutations and immune evasion.
format Online
Article
Text
id pubmed-4868954
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-48689542016-11-18 Regulators of complement activity mediate inhibitory mechanisms through a common C3b‐binding mode Forneris, Federico Wu, Jin Xue, Xiaoguang Ricklin, Daniel Lin, Zhuoer Sfyroera, Georgia Tzekou, Apostolia Volokhina, Elena Granneman, Joke CM Hauhart, Richard Bertram, Paula Liszewski, M Kathryn Atkinson, John P Lambris, John D Gros, Piet EMBO J Articles Regulators of complement activation (RCA) inhibit complement‐induced immune responses on healthy host tissues. We present crystal structures of human RCA (MCP, DAF, and CR1) and a smallpox virus homolog (SPICE) bound to complement component C3b. Our structural data reveal that up to four consecutive homologous CCP domains (i–iv), responsible for inhibition, bind in the same orientation and extended arrangement at a shared binding platform on C3b. Large sequence variations in CCP domains explain the diverse C3b‐binding patterns, with limited or no contribution of some individual domains, while all regulators show extensive contacts with C3b for the domains at the third site. A variation of ~100° rotation around the longitudinal axis is observed for domains binding at the fourth site on C3b, without affecting the overall binding mode. The data suggest a common evolutionary origin for both inhibitory mechanisms, called decay acceleration and cofactor activity, with variable C3b binding through domains at sites ii, iii, and iv, and provide a framework for understanding RCA disease‐related mutations and immune evasion. John Wiley and Sons Inc. 2016-03-24 2016-05-17 /pmc/articles/PMC4868954/ /pubmed/27013439 http://dx.doi.org/10.15252/embj.201593673 Text en © 2016 The Authors. Published under the terms of the CC BY NC ND 4.0 license This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Articles
Forneris, Federico
Wu, Jin
Xue, Xiaoguang
Ricklin, Daniel
Lin, Zhuoer
Sfyroera, Georgia
Tzekou, Apostolia
Volokhina, Elena
Granneman, Joke CM
Hauhart, Richard
Bertram, Paula
Liszewski, M Kathryn
Atkinson, John P
Lambris, John D
Gros, Piet
Regulators of complement activity mediate inhibitory mechanisms through a common C3b‐binding mode
title Regulators of complement activity mediate inhibitory mechanisms through a common C3b‐binding mode
title_full Regulators of complement activity mediate inhibitory mechanisms through a common C3b‐binding mode
title_fullStr Regulators of complement activity mediate inhibitory mechanisms through a common C3b‐binding mode
title_full_unstemmed Regulators of complement activity mediate inhibitory mechanisms through a common C3b‐binding mode
title_short Regulators of complement activity mediate inhibitory mechanisms through a common C3b‐binding mode
title_sort regulators of complement activity mediate inhibitory mechanisms through a common c3b‐binding mode
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868954/
https://www.ncbi.nlm.nih.gov/pubmed/27013439
http://dx.doi.org/10.15252/embj.201593673
work_keys_str_mv AT fornerisfederico regulatorsofcomplementactivitymediateinhibitorymechanismsthroughacommonc3bbindingmode
AT wujin regulatorsofcomplementactivitymediateinhibitorymechanismsthroughacommonc3bbindingmode
AT xuexiaoguang regulatorsofcomplementactivitymediateinhibitorymechanismsthroughacommonc3bbindingmode
AT ricklindaniel regulatorsofcomplementactivitymediateinhibitorymechanismsthroughacommonc3bbindingmode
AT linzhuoer regulatorsofcomplementactivitymediateinhibitorymechanismsthroughacommonc3bbindingmode
AT sfyroerageorgia regulatorsofcomplementactivitymediateinhibitorymechanismsthroughacommonc3bbindingmode
AT tzekouapostolia regulatorsofcomplementactivitymediateinhibitorymechanismsthroughacommonc3bbindingmode
AT volokhinaelena regulatorsofcomplementactivitymediateinhibitorymechanismsthroughacommonc3bbindingmode
AT grannemanjokecm regulatorsofcomplementactivitymediateinhibitorymechanismsthroughacommonc3bbindingmode
AT hauhartrichard regulatorsofcomplementactivitymediateinhibitorymechanismsthroughacommonc3bbindingmode
AT bertrampaula regulatorsofcomplementactivitymediateinhibitorymechanismsthroughacommonc3bbindingmode
AT liszewskimkathryn regulatorsofcomplementactivitymediateinhibitorymechanismsthroughacommonc3bbindingmode
AT atkinsonjohnp regulatorsofcomplementactivitymediateinhibitorymechanismsthroughacommonc3bbindingmode
AT lambrisjohnd regulatorsofcomplementactivitymediateinhibitorymechanismsthroughacommonc3bbindingmode
AT grospiet regulatorsofcomplementactivitymediateinhibitorymechanismsthroughacommonc3bbindingmode